These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22009789)

  • 21. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
    Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
    Gómez García EB; Oosterwijk JC; Timmermans M; van Asperen CJ; Hogervorst FB; Hoogerbrugge N; Oldenburg R; Verhoef S; Dommering CJ; Ausems MG; van Os TA; van der Hout AH; Ligtenberg M; van den Ouweland A; van der Luijt RB; Wijnen JT; Gille JJ; Lindsey PJ; Devilee P; Blok MJ; Vreeswijk MP
    Breast Cancer Res; 2009; 11(1):R8. PubMed ID: 19200354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unified mixed-effects model for rare-variant association in sequencing studies.
    Sun J; Zheng Y; Hsu L
    Genet Epidemiol; 2013 May; 37(4):334-44. PubMed ID: 23483651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fast and noise-resilient approach to detect rare-variant associations with deep sequencing data for complex disorders.
    Cheung YH; Wang G; Leal SM; Wang S
    Genet Epidemiol; 2012 Nov; 36(7):675-85. PubMed ID: 22865616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting disease association signals with multiple genetic variants and covariates.
    Cheng KF; Lee JY
    Stat Methods Med Res; 2017 Jun; 26(3):1281-1294. PubMed ID: 25733545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
    Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
    PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting Clustered Independent Rare Variant Associations Using Genetic Algorithms.
    Souza MG; Vallejo EE; Estrada K
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(3):932-939. PubMed ID: 31403438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resequencing of pooled DNA for detecting disease associations with rare variants.
    Wang T; Lin CY; Rohan TE; Ye K
    Genet Epidemiol; 2010 Jul; 34(5):492-501. PubMed ID: 20578089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.
    Pruss D; Morris B; Hughes E; Eggington JM; Esterling L; Robinson BS; van Kan A; Fernandes PH; Roa BB; Gutin A; Wenstrup RJ; Bowles KR
    Breast Cancer Res Treat; 2014 Aug; 147(1):119-32. PubMed ID: 25085752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comparison Study of Fixed and Mixed Effect Models for Gene Level Association Studies of Complex Traits.
    Fan R; Chiu CY; Jung J; Weeks DE; Wilson AF; Bailey-Wilson JE; Amos CI; Chen Z; Mills JL; Xiong M
    Genet Epidemiol; 2016 Dec; 40(8):702-721. PubMed ID: 27374056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge.
    Padilla N; Moles-Fernández A; Riera C; Montalban G; Özkan S; Ootes L; Bonache S; Díez O; Gutiérrez-Enríquez S; de la Cruz X
    Hum Mutat; 2019 Sep; 40(9):1593-1611. PubMed ID: 31112341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
    Borg A; Haile RW; Malone KE; Capanu M; Diep A; Törngren T; Teraoka S; Begg CB; Thomas DC; Concannon P; Mellemkjaer L; Bernstein L; Tellhed L; Xue S; Olson ER; Liang X; Dolle J; Børresen-Dale AL; Bernstein JL
    Hum Mutat; 2010 Mar; 31(3):E1200-40. PubMed ID: 20104584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population frequencies of pathogenic alleles of BRCA1 and BRCA2: analysis of 173 Danish breast cancer pedigrees using the BOADICEA model.
    Terkelsen T; Christensen LL; Fenton DC; Jensen UB; Sunde L; Thomassen M; Skytte AB
    Fam Cancer; 2019 Oct; 18(4):381-388. PubMed ID: 31435815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of Complex Diseases at Gene Level with Generalized Functional Linear Models.
    Fan R; Wang Y; Chiu CY; Chen W; Ren H; Li Y; Boehnke M; Amos CI; Moore JH; Xiong M
    Genetics; 2016 Feb; 202(2):457-70. PubMed ID: 26715663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.
    Al Hannan F; Keogh MB; Taha S; Al Buainain L
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00771. PubMed ID: 31131559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants.
    Inagaki-Kawata Y; Yoshida K; Kawaguchi-Sakita N; Kawashima M; Nishimura T; Senda N; Shiozawa Y; Takeuchi Y; Inoue Y; Sato-Otsubo A; Fujii Y; Nannya Y; Suzuki E; Takada M; Tanaka H; Shiraishi Y; Chiba K; Kataoka Y; Torii M; Yoshibayashi H; Yamagami K; Okamura R; Moriguchi Y; Kato H; Tsuyuki S; Yamauchi A; Suwa H; Inamoto T; Miyano S; Ogawa S; Toi M
    Commun Biol; 2020 Oct; 3(1):578. PubMed ID: 33067557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases.
    Dudbridge F; Fletcher O; Walker K; Johnson N; Orr N; Dos Santos Silva I; Peto J
    Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):262-72. PubMed ID: 22028405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.